|
Post by Andre on Mar 6, 2007 12:46:02 GMT -5
Hi David, according to Website of the company Asklepios the products Launch takes place 2010. What do you think? Link: www.askbio.com then "Patient Info" Andre
|
|
|
Post by David Feder on Mar 6, 2007 17:24:31 GMT -5
|
|
|
Post by Glen on Mar 7, 2007 2:44:48 GMT -5
Dr. Feder,
In gene therapy the replacement gene is attenuated to only the important parts. In the studies with mice was the gene fully functional after gene therapy?
Is the goal of gene therapy to turn DMD into Beckers or to have a fully functional gene?
Thanks, Glen
|
|
|
Post by David Feder on Mar 7, 2007 15:07:19 GMT -5
It's possible to cure with gene therapy. But I don't know the effect of therapy in muscles with some degeneration. How much muscle the therapy can cure? If only few muscles replace the gene (less than 40%) probably the functional results will be low and the disease will be more similar to BMD.
|
|
|
Post by Andre on Mar 8, 2007 9:54:20 GMT -5
Hi David,
in the efficiency in the gene therapy from Dr. Cossu better then 40% muscles ? It gives other realistic research for 80% ? To live „normal“ how much muscles we need (replace 80%) ?
Thanks Andre
|
|
|
Post by David Feder on Mar 9, 2007 20:50:50 GMT -5
|
|
|
Post by Andre on Mar 21, 2007 6:28:28 GMT -5
Hi David,
Pat Furlong wrote to Biostrophin 2010: --- The goal is 2010 though they are now conducting studies in the dogs to insure that there are able to deliver the aav systemically without adverse effects. --- If they test now with animals, how do they want to arrive their goal 2010? Is that possible?
André
|
|
|
Post by David Feder on Mar 21, 2007 15:26:56 GMT -5
André: Probably they will start human trial in 2010. Results in 2015 or more.
|
|
|
Post by ifyokze on Sept 4, 2019 8:29:50 GMT -5
|
|